SNS Insider Unveils Strategic Insights into the U.S. Long Read Sequencing Market's Exponential Growth-Valued at USD 220.26 Million in 2023-While the ...

A month has gone by since the last earnings report for Steris. Shares have lost about 1.8% in that time frame, ...

It is anticipated that the global biomarker testing market will experience rapid growth, with a valuation of approximately USD 122.8 billion by 2033, and a compound annual growth rate (CAGR) of 10.4% ...

PacBio reported $36.9 million in Q1 revenue ... environment is having an impact on our ability to place more instruments, particularly Revio systems at academic customers, we are encouraged ...

Going forward, PacBio said it will “focus on its highest-impact long-read platform development initiatives” via its HiFi sequencing instruments, including the Vega benchtop analyzer announced ...

of which approximately 45% went to new customers of PacBio instruments. The company also recorded impressive growth in its HiFi sequencing technology, with genomic data output increasing by 81% in ...

MENLO PARK, CA – Pacific Biosciences of California, Inc. (NASDAQ:PACB), a leader in laboratory analytical instruments with a market capitalization of $357.59 million, has entered into a ...

Vega offers the same on-board computing features available on other PacBio instruments, but features an easy-to-operate, integrated workflow with only two consumables. To further simplify setup, ...

Vega offers the same on-board computing features available on other PacBio instruments, but features an easy-to-operate, integrated workflow with only two consumables. To further simplify setup ...